Medicinal cannabis is, without doubt, one of the world’s fastest growing and most innovative industrial sectors. Since the turn of the century, researchers have revealed the immense potential of the drug to treat conditions from epilepsy to MS to cancer.

As a result, many countries have legalised cannabis for medicinal use, and a new sector has emerged that could be worth €115.7 billion by 2028 in Europe alone. But this is a complex new area. Memery Crystal has the expertise to help you navigate it.

Your team

Nick DavisSenior Partner, Corporate Partner

Contact Nick


Contact Nick Davis

    Please complete all fields

    • ?

      I will use your email address to contact you in reference to your message. We will not pass this on to any 3rd parties, in accordance with our terms.

    View team

    "The individuals in the team are always available and willing to go the extra mile to close deals."

    Legal 500, 2020

    In 2018, the UK started the process of legalising medicinal cannabis. At Memery Crystal, we believe this law change represents a chance to benefit thousands of patients, support scientific innovation and fuel economic prosperity. We are committed to supporting this exciting opportunity.

    The UK medicinal cannabis sector may be embryonic, but we are already at the centre of it. Memery Crystal are the leading full service UK law firm advising the medicinal cannabis sector on business set up, capital markets, mergers & acquisitions, private fundraising, licensing and commercial contracts. Our team also produced The Green Report in September 2018 to aid conversation in the emerging UK medicinal cannabis investment landscape.

    Our team is well equipped to advise on the broad range of matters that this complex but highly promising new space encompasses.

    What we're thinking...

    taxonomy="sector" taxonomy_terms="cannabis" taxonomy_operator="IN"

    What to do next

    Contact our expert

    Nick DavisSenior Partner, Corporate Partner

    Contact Nick